RM

Ross La Motte-Mohs

SC Sunnybrook Health Sciences Centre: 3 patents #15 of 102Top 15%
📍 Germantown, MD: #108 of 905 inventorsTop 15%
🗺 Maryland: #3,153 of 35,612 inventorsTop 9%
Overall (All Time): #486,605 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11858991 LAG-3-binding molecules and methods of use thereof Kalpana Shah, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore, Ezio Bonvini +1 more 2024-01-02
11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 Leslie S. Johnson, Gurunadh Reddy Chichili, Kalpana Shah, Paul A. Moore, Ezio Bonvini +1 more 2023-12-12
11098119 Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof Ezio Bonvini, Leslie S. Johnson, Kalpana Shah, Paul A. Moore, Scott Koenig 2021-08-24
11072653 LAG-3-binding molecules and methods of use thereof Kalpana Shah, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore, Ezio Bonvini +1 more 2021-07-27
10954301 Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof Leslie S. Johnson, Gurunadh Reddy Chichili, Kalpana Shah, Paul A. Moore, Ezio Bonvini +1 more 2021-03-23
10577422 PD-1-binding molecules and methods of use thereof Kalpana Shah, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore, Ezio Bonvini +1 more 2020-03-03
10266805 Human progenitor T-cells into NK cells Juan Carlos Zuniga-Pflucker, Geneve Awong 2019-04-23
10160806 Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof Ezio Bonvini, Leslie S. Johnson, Kalpana Shah, Paul A. Moore, Scott Koenig 2018-12-25
9533009 Producing human CD34+CD7+CD5+CD1a− progenitor T cells and method of treatment Juan Carlos Zuniga-Pflucker, Geneve Awong 2017-01-03
8772028 CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using Juan Carlos Zuniga-Pflucker, Geneve Awong 2014-07-08